Luas Diagnostics (LD) has signed an option agreement with Molecular Warehouse (MW) of Guildford, Surrey. Under the terms of the agreement MW, who are a 49% shareholder in LD, will

A saliva-based test for COVID-19 providing results directly to patients in minutes is being developed as a result of a new collaboration between Luas Diagnostics and the University of Birmingham.